Inventor
Yusuke OGITANI
Inventor
JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C07DHeterocyclic compounds17%
Y02PClimate change mitigation technologies in the production or processing of goods8%
PatentTitleYear
12,497,465Combination of antibody-drug conjugate and tubulin inhibitor202512,186,310Antibody-drug conjugate202511,795,236Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate202311,633,493Antibody-drug conjugate202311,584,800Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate202311,185,594(Anti-HER2 antibody)-drug conjugate2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to DAIICHI SANKYO CO LTD (6)· patent assignee history
2021–2025Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| DAIICHI SANKYO CO LTD | 6 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 6 | 2021–2025 |